Perspective Therapeutics, Inc. — Director's Dealing 2024

Jun 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2024-06-20

Reporting Person: Spoor Johan M. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-20	Stock option (right to buy)	$10.65	A	500000	Acquired	2034-06-20	Common Stock (500000)	Direct

Footnotes

F1: Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (06/20/2024), subject to a continued service relationship.